26 Dec, EOD - Indian

SENSEX 78472.48 (0.00)

Nifty 50 23750.2 (0.10)

Nifty Bank 51170.7 (-0.12)

Nifty IT 43664.25 (-0.01)

Nifty Midcap 100 57125.7 (0.12)

Nifty Next 50 69165.85 (0.45)

Nifty Pharma 22712.55 (0.68)

Nifty Smallcap 100 18728.65 (-0.02)

26 Dec, EOD - Global

NIKKEI 225 39568.06 (1.12)

HANG SENG 20098.29 (1.08)

S&P 6026.04 (-0.31)

LOGIN HERE

Procter & Gamble Health Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 500126 | NSE Symbol : PGHL | ISIN : INE199A01012 | Industry : Pharmaceuticals |


Chairman's Speech

Dear Shareholders,

I am delighted to connect with you to share the Annual Report ofyour Company, and take you through ourjourneyofCetting Closerto ourconsumers, patients, healthcare practitioners, customers and partners through the year 2022-23.

Getting closer symbolizes your Company?s commitment to being there for our consumers and patients when and where they need us, to bridging the gap between cutting-edge scientific research and patient care, to extending healthcare to our communities, and, last but not the least, to serving and caring for our own.

Over the past year, we continued to invest towards consumer awareness programs across therapy areas towards early diagnoses, timely treatment and improved outcomes.

To help drive visibility in our operating categories, we introduced various continuous in-clinic education initiatives, consumer awareness campaigns, and strategic collaborations with new-age digital platforms. Through scientifically backed communication disseminated across new- age social and digital platforms, we worked towards raising awareness about Iron Deficiency Anemia through the chants of Bolo India Na Na Anemia!? powered by

Livogen; our flagship brand Neurobion empowered consumers to identify signs of nerve damage and seek timely management to be able to Feel Life? again; Polybion, spearheaded conversations on the role played by B vitamins in bolstering recovery, energy, and immunity, thereby helping people to Stay Always On?; Evion, helped educate consumers on the need to nourish from within to radiate beauty on the outside through Evion In BeautyOn?; and, and Nasivion reiterated the promise to provide Fast Relief for nasal congestion. The year alsowitnessed us set a new benchmark in association with the Indian Medical Association, byachieving a GUINNESS WORLD RECORD™ for the Largest Attendance for a Virtual Pharmaceutical Conference in one day? during our first-ever Phygital? Recovery Summit 2023.

Our collaboration with healthcare professionals, pharmacists, and healthcare organizations, helped foster betterscientific collaboration and knowledge-sharing within the medical fraternity, thereby facilitating to build an ecosystem empowering HCPs and pharmacists to deliver the best possible care to patients. We did this through bespoke scientific exchange forums such as Blood Health Forum, Nerve Care Forum, the Care Summit, Recovery Summit, thereby engaging experts within the industry. These engagements helped drive ourcore beliefof bringing care closer to patients through innovative approaches.

We bolstered ourgo-to-market strategy and strengthened our partnerships across omni channel stores, increasing the availability and access ofour brands across online and offline platforms, thereby helping meet the needs of our consumers and customers.

Together, these efforts have helped us deliver resilient performance and consistent growth through the year amidst significant industry headwinds, a tough competitive landscape and category slowdown.

Your Company?s continues to be guided by our strong citizenship framework based on key pillars ofCommunity Impact, Equality and Inclusion and Environmental Sustainability, with a strong foundation of Ethics and Corporate Social Responsibility (CSR) guiding everything we do. SEHAT, our flagship CSR program, continued to remain a priorityduring this fiscal yearwhere we continued to strengthen public health through our strategic initiatives. Our Employees also made a strong contribution to SEHAT through volunteering initiatives with our partner NGOs, and our Annual Joy of Giving Internal Campaign.

Moving ahead, we remain focused on our integrated strategywhich comprises a portfolioofquality, trusted and highly recommended healthcare productswhere performance drives brand choice; with superiority across product, package, brand communication, retail execution, and value; productivity; constructive disruption; and an agile, empowered organization. We believe these are the right strategies to help us navigate our short and mid-term challenges and help us deliver balanced growth.

I would like to take this opportunity to thank each ofyou, our dear shareholders, for your steadfast support.

Step by step, quarter on quarter, initiative by initiative we continue determined to become a leading Company in Consumer Health in India. With a strategic interest in the health and well-being ofconsumers, strong portfolio of brands backed by science and trusted by doctors, consumers and pharmacists, the passion and perseverance ofour talented and passionate team, and yoursupport and encouragement, we believe we can make it happen.